---
title: "Double Medical Technology Inc. (002901.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002901.SZ.md"
symbol: "002901.SZ"
name: "Double Medical Technology Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T18:42:53.583Z"
locales:
  - [en](https://longbridge.com/en/quote/002901.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002901.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002901.SZ.md)
---

# Double Medical Technology Inc. (002901.SZ)

## Company Overview

Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.double-medical.com](https://www.double-medical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.25)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 7 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 19.19% |  |
| Net Profit YoY | 61.51% |  |
| P/B Ratio | 4.50 |  |
| Dividend Ratio | 1.21% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 16781024716.53 |  |
| Revenue | 2696808708.52 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 18.59% | A |
| Profit Margin | 23.89% | A |
| Gross Margin | 74.16% | A |
| Revenue YoY | 19.19% | B |
| Net Profit YoY | 61.51% | B |
| Total Assets YoY | 12.62% | B |
| Net Assets YoY | 16.57% | B |
| Cash Flow Margin | 136.18% | B |
| OCF YoY | 19.19% | B |
| Turnover | 0.57 | C |
| Gearing Ratio | 23.36% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Double Medical Technology Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "19.19%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "61.51%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.50",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.21%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "16781024716.53",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2696808708.52",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "18.59%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "23.89%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "74.16%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "19.19%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "61.51%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.62%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "16.57%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "136.18%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "19.19%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.57",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "23.36%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 26.19 | 9/64 | 47.80 | 37.84 | 34.63 |
| PB | 4.52 | 51/64 | 6.93 | 5.97 | 4.95 |
| PS (TTM) | 6.26 | 32/64 | 9.29 | 8.05 | 6.98 |
| Dividend Yield | 1.21% | 25/64 | 1.16% | 1.02% | 0.91% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-12T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 40.68 |
| Highest Target | 43.00 |
| Lowest Target | 43.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002901.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002901.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/002901.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002901.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**